about
Profound block in thymocyte development in mice lacking p56lckGenetically predicted longer telomere length is associated with increased risk of B-cell lymphoma subtypesHerpes-virus infection in patients with Langerhans cell histiocytosis: a case-controlled sero-epidemiological study, and in situ analysis.Carbon dioxide is largely responsible for the acute inflammatory effects of tobacco smoke.Frequent engagement of RelB activation is critical for cell survival in multiple myeloma.Inherited STING-activating mutation underlies a familial inflammatory syndrome with lupus-like manifestationsInfluence of Tumor Location on the Composition of Immune Infiltrate and Its Impact on Patient Survival. Lessons from DCBCL and Animal Models.In Situ Hepatitis C NS3 Protein Detection Is Associated with High Grade Features in Hepatitis C-Associated B-Cell Non-Hodgkin Lymphomas.Biology of murine gamma delta T cells.The expression of 16 genes related to the cell of origin and immune response predicts survival in elderly patients with diffuse large B-cell lymphoma treated with CHOP and rituximab.Lymphoplasmacytic lymphoma and other non-marginal zone lymphomas with plasmacytic differentiation.FCGR3A/2A polymorphisms and diffuse large B-cell lymphoma outcome treated with immunochemotherapy: a meta-analysis on 1134 patients from two prospective cohorts.The reliability of immunohistochemical analysis of the tumor microenvironment in follicular lymphoma: a validation study from the Lunenburg Lymphoma Biomarker ConsortiumSkin Biopsy in Netherton Syndrome: A Histological Review of a Large Series and New Findings.Recurrent mutations of the exportin 1 gene (XPO1) and their impact on selective inhibitor of nuclear export compounds sensitivity in primary mediastinal B-cell lymphoma.Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase δ syndrome 2: A cohort study.Diffuse large B-cell lymphomas with CDKN2A deletion have a distinct gene expression signature and a poor prognosis under R-CHOP treatment: a GELA study.Autoimmune hemolytic anemia and nodular lymphocyte-predominant hodgkin lymphoma: a rare association.Defective anti-polysaccharide response and splenic marginal zone disorganization in ALPS patients.Reproducibility of immunohistochemical scoring for epidermal growth factor receptor expression in non-small cell lung cancer: round robin test.Intensive conventional chemotherapy (ACVBP regimen) compared with standard CHOP for poor-prognosis aggressive non-Hodgkin lymphoma.ACVBP versus CHOP plus radiotherapy for localized aggressive lymphoma.FcgammaRIIB is differentially expressed during B cell maturation and in B-cell lymphomas.BCL2 expression but not MYC and BCL2 coexpression predicts survival in elderly patients with diffuse large B-cell lymphoma independently of cell of origin in the phase 3 LNH03-6B trial.Retinal dysplasia in mice lacking p56lck.Plasmacytoid dendritic cells accumulate in spleens from chronically HIV-infected patients but barely participate in interferon-alpha expression.Dose-dense rituximab-CHOP compared with standard rituximab-CHOP in elderly patients with diffuse large B-cell lymphoma (the LNH03-6B study): a randomised phase 3 trial.Correlation between molecular and histopathological diagnoses of B cell lymphomas in bone marrow biopsy and aspirates.The detection of CD14 and CD16 in paraffin-embedded bone marrow biopsies is useful for the diagnosis of chronic myelomonocytic leukemia.Evaluation of a low density DNA microarray for small B-cell non-Hodgkin lymphoma differential diagnosis.Next-Generation Sequencing in Diffuse Large B-Cell Lymphoma Highlights Molecular Divergence and Therapeutic Opportunities: a LYSA Study.Biological and Clinical Relevance of Associated Genomic Alterations in MYD88 L265P and non-L265P-Mutated Diffuse Large B-Cell Lymphoma: Analysis of 361 Cases.Diffuse large B-cell lymphoma of Waldeyer's ring has distinct clinicopathologic features: a GELA study.Critical role of monocytes to support normal B cell and diffuse large B cell lymphoma survival and proliferation.Consecutive conjunctival melanoma and extranodal marginal zone B-cell lymphoma of MALT type in an adult patient.Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B): an open-label randomised phase 3 trial.CD14 and CD169 expression in human lymph nodes and spleen: specific expansion of CD14+CD169− monocyte-derived cells in diffuse large B-cell lymphomasBlood vessel invasion in resected non small cell lung carcinomas is predictive of metastatic occurrenceDacarbazine Promotes Stromal Remodeling and Lymphocyte Infiltration in Cutaneous Melanoma LesionsAntithrombin is not protective against renal ischaemia-reperfusion injury
P50
Q24298882-0C90BEDE-BCE9-4150-9BD8-AA8D02359FE4Q28393571-D1110740-2E5C-4F78-9B34-6CE4D5E350F0Q33371209-A7F64530-EA86-4CB0-809B-6C22EC37567FQ34109909-F736A692-CFB9-4293-A805-8C0A30C78E80Q34650781-E1A4EE46-2571-419B-AD57-5EC8A86B87E7Q35145346-00B5989F-9432-4874-B697-368705603CD5Q35931598-A3218E76-FDF9-4BB8-B87A-AEB330939E8FQ36039573-9B1EF764-59DA-4276-93C7-EA7FA5A47983Q37133937-345FDF7E-A080-4830-A43D-EEB2A0A6437EQ37174123-A5DD5AF2-DDA4-42ED-9058-E51539B35E4DQ37901235-4EA3A103-2DC3-4022-A89F-35BA1BCA95C7Q38391516-0B5D2E36-4E31-4F9C-B7DF-B925E19AA307Q38572605-8F182BFA-C772-4D59-BBED-16CCF6A8077CQ38716088-77353B3E-288F-4084-BA82-318265B5CF96Q38764010-0C01F0C5-8786-4158-A97C-EB744859A5E0Q38843413-B21C9B24-1F1D-47ED-85B8-AE866337CD04Q39877366-56589270-8221-4FFD-A78F-F0F5A57A4990Q40246473-D60E6436-EE50-4034-B4C9-95CA3D0E38C9Q43460814-2B224542-F038-4EA3-A3ED-20E4CC9C4948Q44015403-8895DBAD-1F4E-44D6-80A5-AD80E18440B5Q44550481-6E7188E6-82E0-4DB6-8A93-0B944B38C240Q46402373-F4F49BA9-A1B4-4788-AF10-8475C3597BC7Q47320235-03867A33-4648-450F-9BDA-DCEEC4875783Q47920784-52684347-1FAF-413E-87DF-62BFD4E05249Q47992955-F0DE10C2-87AE-4D15-B21C-C03F0E5D9FAEQ48007772-33EC0597-260A-4EC3-B257-81017E3E8987Q50492479-F32EAEBE-B1A8-4F1B-B6A3-63978257AB19Q51746282-2B1006BF-97ED-4406-BEDA-AA785BC7D93AQ51799749-13708D36-1444-4DE9-B865-7DB5BBA4FE7DQ51848204-EFC56B78-B7B8-4F31-8ADD-1B2C438FD749Q52887085-97DA17C9-0DA6-42E3-B85C-5B5BB3A69928Q52948207-64406192-576C-44BA-894C-90D1084AB612Q53128427-CA0F55D8-9DC1-4FB5-92F0-D709D94FD1D7Q53545848-F9403738-19A4-408F-B077-28525FE8F61CQ54675827-C415A5A2-3C31-4E57-BD06-DB9FBEE79734Q55055249-9D7F78BE-5BFF-4A38-BA35-71E56EFD741CQ56966046-DD699149-A1A5-45DB-B68F-FDBFCF2C0144Q58416209-1D91687C-5C20-4298-AED4-A4BEBB65A3EFQ58621119-D92E5713-EBC1-4D9B-8420-CD70241E4D55Q61835245-56095B10-33A5-494A-8E32-7F1110021F64
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Thierry J Molina
@ast
Thierry J Molina
@en
Thierry J Molina
@es
Thierry J Molina
@nl
type
label
Thierry J Molina
@ast
Thierry J Molina
@en
Thierry J Molina
@es
Thierry J Molina
@nl
prefLabel
Thierry J Molina
@ast
Thierry J Molina
@en
Thierry J Molina
@es
Thierry J Molina
@nl
P106
P31
P496
0000-0002-3929-9754